Search - tctmd.com

Displaying 321 - 340 of 732

Sort: Relevancy | Date

News Conference News ACC 2019

Info Gleaned From FFRCT Has Durable Impact on 1-Year Outcomes: ADVANCE Registry

Caitlin E. Cox

March 18, 2019

News Conference News ACC 2019

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

L.A. McKeown

March 18, 2019

News Conference News ACC 2019

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

L.A. McKeown

March 18, 2019

Presentation ACC 2019

Chemical Renal Denervation with Alcohol: The Post-Market Study Data and The Target BP Program

Presenter: Horst Sievert

March 18, 2019

Presentation ACC 2019

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Presenter: Suzanne V. Arnold

March 18, 2019

Ticagrelor Monotherapy Beyond One Month Versus Conventional Therapy On Adjudicated Ischemic And Bleeding Endpoints Following Drug Eluting Sent Implantation. Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presentation ACC 2019

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presenter: Marco Valgimigli

March 18, 2019

Presentation ACC 2019

Impact of FFRCT on 1-Year Outcomes: Lessons from the ADVANCE Registry

Presenter: Manesh Patel

March 18, 2019

Presentation ACC 2019

Blinded Physiological Assessment of Residual Ischemia after Successful Angiographic PCI

Presenter: Allen Jeremias

March 18, 2019

News Opinion Editor's Corner ACC 2019

Live From New Orleans: Days 2 and 3 at ACC 2019

Shelley Wood

March 18, 2019

Presentation ACC 2019

First Randomized Human Experience with a Ticagrelor Reversal Agent

Presenter: Deepak L. Bhatt

March 18, 2019

Presentation ACC 2019

1-Year Outcomes from the CardioMEMS Post-Approval Study

Presenter: David M. Shavelle

March 18, 2019

News Opinion Off Script ACC 2019

Off Script: As the Quantification of Cath Lab Quality Gets an Upgrade, Frustrations Abound

Kwan S. Lee

March 17, 2019

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

Presentation ACC 2019

Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial

Presenter: Federico M. Asch

March 17, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Caitlin E. Cox

March 17, 2019

Presentation ACC 2019

Results from the PANACHE Phase 2b RCT

Presenter: Sanjiv J. Shah

March 17, 2019

Advertisement

Info Gleaned From FFRCT Has Durable Impact on 1-Year Outcomes: ADVANCE Registry

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

Chemical Renal Denervation with Alcohol: The Post-Market Study Data and The Target BP Program

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Impact of FFRCT on 1-Year Outcomes: Lessons from the ADVANCE Registry

Blinded Physiological Assessment of Residual Ischemia after Successful Angiographic PCI

Live From New Orleans: Days 2 and 3 at ACC 2019

First Randomized Human Experience with a Ticagrelor Reversal Agent

1-Year Outcomes from the CardioMEMS Post-Approval Study

Off Script: As the Quantification of Cath Lab Quality Gets an Upgrade, Frustrations Abound

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial

Primary Results From the Evolut Low Risk Trial

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Results from the PANACHE Phase 2b RCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content